Correlation Between Ancorathelen Small and Guidepath Tactical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ancorathelen Small and Guidepath Tactical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ancorathelen Small and Guidepath Tactical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ancorathelen Small Mid Cap and Guidepath Tactical Allocation, you can compare the effects of market volatilities on Ancorathelen Small and Guidepath Tactical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ancorathelen Small with a short position of Guidepath Tactical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ancorathelen Small and Guidepath Tactical.

Diversification Opportunities for Ancorathelen Small and Guidepath Tactical

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Ancorathelen and Guidepath is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Ancorathelen Small Mid Cap and Guidepath Tactical Allocation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guidepath Tactical and Ancorathelen Small is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ancorathelen Small Mid Cap are associated (or correlated) with Guidepath Tactical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guidepath Tactical has no effect on the direction of Ancorathelen Small i.e., Ancorathelen Small and Guidepath Tactical go up and down completely randomly.

Pair Corralation between Ancorathelen Small and Guidepath Tactical

Assuming the 90 days horizon Ancorathelen Small Mid Cap is expected to generate 1.32 times more return on investment than Guidepath Tactical. However, Ancorathelen Small is 1.32 times more volatile than Guidepath Tactical Allocation. It trades about 0.1 of its potential returns per unit of risk. Guidepath Tactical Allocation is currently generating about 0.12 per unit of risk. If you would invest  1,738  in Ancorathelen Small Mid Cap on September 12, 2024 and sell it today you would earn a total of  494.00  from holding Ancorathelen Small Mid Cap or generate 28.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy99.6%
ValuesDaily Returns

Ancorathelen Small Mid Cap  vs.  Guidepath Tactical Allocation

 Performance 
       Timeline  
Ancorathelen Small Mid 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ancorathelen Small Mid Cap are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Ancorathelen Small may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Guidepath Tactical 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Guidepath Tactical Allocation are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Guidepath Tactical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Ancorathelen Small and Guidepath Tactical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ancorathelen Small and Guidepath Tactical

The main advantage of trading using opposite Ancorathelen Small and Guidepath Tactical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ancorathelen Small position performs unexpectedly, Guidepath Tactical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guidepath Tactical will offset losses from the drop in Guidepath Tactical's long position.
The idea behind Ancorathelen Small Mid Cap and Guidepath Tactical Allocation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators